Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy (Duchenne), Friedreich’s ataxia (FA), catecholaminergic polymorphic ventricular tachycardia (CPVT), TNNT2-mediated dilated cardiomyopathy, BAG3-mediated dilated cardiomyopathy, and additional fatal, genetic cardiac diseases. We are advancing a diverse pipeline and delivery platform in the pursuit of uniting experts in science, technology, disease management, and care. Patient-focused and founded by those directly impacted by Duchenne, Solid’s mission is to improve the daily lives of patients living with devastating rare diseases. We are seeking a Principal Biostatistician to play a pivotal role in the drug development of multiple assets through designing clinical trials, determining appropriate sample sizes, and applying rigorous statistical methods to evaluate whether a treatment is safe and effective. The Principal Biostatistician will collaborate closely with clinicians, data managers, and regulatory teams to ensure that study protocols are scientifically sound and that the resulting data can withstand regulatory scrutiny. The work will involve analyzing complex datasets, interpreting results in a scientifically or clinically meaningful way, and preparing statistical reports that support submissions to agencies like the FDA. In essence, this role will serve as the scientific bridge between raw clinical data and the evidence needed to bring new therapies to patients, a responsibility that demands both technical mastery and strategic insight on required statistical rigor in clinical research. This role will report to the Senior Director of Biostatistics and AI/ML and will be remote.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Principal
Education Level
Ph.D. or professional degree
Number of Employees
51-100 employees